Citation: Xiangqian Cao, Chenkai Yang, Xiaodong Zhu, Mengxin Zhao, Yilin Yan, Zhengnan Huang, Jinming Cai, Jingming Zhuang, Shengzhou Li, Wei Li, Bing Shen. Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM[J]. Chinese Chemical Letters, ;2024, 35(8): 109199. doi: 10.1016/j.cclet.2023.109199 shu

Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM

Xiangqian Cao ^{a, 1} ,
Chenkai Yang ^{a, 1} ,
Xiaodong Zhu ^{b, 1} ,
Mengxin Zhao ^b ,
Yilin Yan ^a ,
Zhengnan Huang ^a ,
Jinming Cai ^a ,
Jingming Zhuang ^a ,
Shengzhou Li ^a ,
Wei Li ^{b, *,} ,
Bing Shen ^{a, *,}

a.
Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
b.
Department of Nanomedicine & Shanghai Key Lab of Cell Engineering, Naval Medical University, Shanghai 200433, China

liwei_dds@163.com

urodrshenbing@shsmu.edu.cn

Received Date: 2 July 2023
Revised Date: 10 October 2023
Accepted Date: 12 October 2023
Available Online: 13 October 2023

Figures(4)

Bladder cancer is a common malignant tumor of the urinary system with the potential to be treated by nano drug delivery system. The current work describes the synthesis and characterization of a novel nanomaterial to construct a nano-carrier based on 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatecholine (POPC) loaded doxorubicin (DOX) and embedded with gold nanoparticles and poly(N-isopropyl acrylamide) (PNIPAM) (GNPS@PNIPAM-POPC-DOX, GPPD). The dual-sensitive nanosystem gives simultaneous photothermal treatment and chemotherapy for bladder cancer. In vitro and in vivo properties were assessed using bladder cancer cell lines and mice and GPPD system distribution, tumor inhibition, and biocompatibility are reported. The system had favorable stability, low biological toxicity, controlled release efficiency, photothermal synergistic action, efficient photothermal transition, and favorable tumor suppressive effects. As a result, GPPD is a potential therapeutic approach for bladder cancer.
- Doxorubicin,
- Gold nanoparticles,
- Thermosensitive polymer,
- Photothermal therapy,
- Bladder cancer
1. [1]
  T. Tate, T. Xiang, S.E. Wobker, et al., Nat. Commun. 12 (2021) 6160. doi: 10.1038/s41467-021-26421-6
2. [2]
  R.L. Siegel, K.D. Miller, N.S. Wagle, et al., CA Cancer J. Clin. 73 (2023) 17–48. doi: 10.3322/caac.21763
3. [3]
  P. Jain, H. Kathuria, M. Momin, Pharmacol. Ther. 226 (2021) 107871. doi: 10.1016/j.pharmthera.2021.107871
4. [4]
  J. Gao, S. Ma, X. Zhao, et al., Chin. Chem. Lett. 32 (2021) 3954–3961. doi: 10.1016/j.cclet.2021.06.040
5. [5]
  Q. Xiao, X. Li, C. Liu, et al., Chin. Chem. Lett. 33 (2022) 4191–4196. doi: 10.1016/j.cclet.2022.01.083
6. [6]
  S.K. Huang, E. Mayhew, S. Gilani, et al., Cancer Res. 52 (1992) 6774–6781.
7. [7]
  N. Wang, Y. Zuo, S. Wu, et al., Acta Pharm. Sin. B 12 (2022) 4486–4500. doi: 10.1016/j.apsb.2022.05.032
8. [8]
  C. Huang, L. Zhang, Q. Guo, et al., Adv. Funct. Mater. 31 (2021) 2010637. doi: 10.1002/adfm.202010637
9. [9]
  Q. Li, Z. Shi, F. Zhang, et al., Acta Pharm. Sin. B 12 (2022) 107–134. doi: 10.1016/j.apsb.2021.05.031
10. [10]
  C. Lin, H. Hao, L. Mei, et al., Smart Mater. Med. 1 (2020) 150–167. doi: 10.1016/j.smaim.2020.09.001
11. [11]
  X. Li, J.F. Lovell, J. Yoon, et al., Nat. Rev. Clin. Oncol. 17 (2020) 657–674. doi: 10.1038/s41571-020-0410-2
12. [12]
  M.H. Jazayeri, T. Aghaie, R. Nedaeinia, et al., Cancer Immunol. Immunother. 69 (2020) 1833–1840. doi: 10.1007/s00262-020-02559-y
13. [13]
  S.K. Cho, K. Emoto, L.J. Su, et al., J. Biomed. Nanotechnol. 10 (2014) 1267–1276. doi: 10.1166/jbn.2014.1838
14. [14]
  T. Chen, W. Zeng, C. Tie, et al., Bioact. Mater. 10 (2022) 515–525.
15. [15]
  T.Y. Lin, Y. Li, Q. Liu, et al., Biomaterials 104 (2016) 339–351. doi: 10.1016/j.biomaterials.2016.07.026
16. [16]
  L.R. Hirsch, R.J. Stafford, J.A. Bankson, et al., Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13549–13554. doi: 10.1073/pnas.2232479100
17. [17]
  D.P. O'Neal, L.R. Hirsch, N.J. Halas, et al., Cancer Lett. 209 (2004) 171–176. doi: 10.1016/j.canlet.2004.02.004
18. [18]
  H.M. Smilowitz, L.J. Tarmu, M.M. Sanders, et al., Int. J. Nanomedicine 12 (2017) 7937–7946. doi: 10.2147/IJN.S140977
19. [19]
  J.K. Cheong, V. Popov, E. Alchera, et al., Comput. Biol. Med. 138 (2021) 104881. doi: 10.1016/j.compbiomed.2021.104881
20. [20]
  Y. Kwon, Y. Choi, J. Jang, et al., Pharmaceutics 12 (2020) 204. doi: 10.3390/pharmaceutics12030204
21. [21]
  R. Yadav, S. Kumar, P. Narang, et al., J. Colloid Interface Sci. 582 (2021) 478–487. doi: 10.1016/j.jcis.2020.08.074
22. [22]
  H. Wang, X. Yang, C. Hu, et al., Chin. Chem. Lett. 33 (2022) 4179–4184. doi: 10.1016/j.cclet.2022.02.022
23. [23]
  Z. Shi, Q. Li, L. Mei, Chin. Chem. Lett. 31 (2020) 1345–1356. doi: 10.1016/j.cclet.2020.03.001
24. [24]
  Z. Li, Y. Yang, H. Wei, et al., J. Control. Release 338 (2021) 719–730. doi: 10.1016/j.jconrel.2021.09.005
25. [25]
  W. Li, M. Nakayama, J. Akimoto, et al., Polymer 52 (2011) 3783–3790. doi: 10.1016/j.polymer.2011.06.026
26. [26]
  D. Petroni, C. Riccardi, D. Cavasso, et al., Molecules 26 (2021) 6591. doi: 10.3390/molecules26216591
27. [27]
  X. Zhu, Y. Sun, D. Chen, et al., J. Control. Release 254 (2017) 107–118. doi: 10.1016/j.jconrel.2017.03.038
28. [28]
  H. Zhang, J. Lu, Y. Zhang, et al., Chin. Chem. Lett. 34 (2023) 107450. doi: 10.1016/j.cclet.2022.04.048
29. [29]
  F. Zhang, Y. Hou, M. Zhu, et al., Adv. Sci. 8 (2021) e2102666. doi: 10.1002/advs.202102666
30. [30]
  F. Zhang, D. Chen, Y. Wang, et al., Nanomedicine 12 (2017) 1575–1589. doi: 10.2217/nnm-2017-0126
31. [31]
  F. Zhang, X. Zhu, J. Gong, et al., Nanomedicine 11 (2016) 1993–2006. doi: 10.2217/nnm-2016-0139
32. [32]
  M. Yu, J. Yu, Y. Yi, et al., J. Control. Release 347 (2022) 104–114. doi: 10.1016/j.jconrel.2022.04.047
33. [33]
  W. Li, J. Li, J. Gao, et al., Biomaterials 32 (2011) 3832–3844. doi: 10.1016/j.biomaterials.2011.01.075
1. [1]
  Xuejian Xing , Pan Zhu , E Pang , Shaojing Zhao , Yu Tang , Zheyu Hu , Quchang Ouyang , Minhuan Lan . D-A-D-structured boron-dipyrromethene with aggregation-induced enhanced phototherapeutic efficiency for near-infrared fluorescent and photoacoustic imaging-guided synergistic photodynamic and photothermal cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109452-. doi: 10.1016/j.cclet.2023.109452
2. [2]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
3. [3]
  Leichen Wang , Anqing Mei , Na Li , Xiaohong Ruan , Xu Sun , Yu Cai , Jinjun Shao , Xiaochen Dong . Aza-BODIPY dye with unexpected bromination and high singlet oxygen quantum yield for photoacoustic imaging-guided synergetic photodynamic/photothermal therapy. Chinese Chemical Letters, 2024, 35(6): 108974-. doi: 10.1016/j.cclet.2023.108974
4. [4]
  Yongkang Yue , Zhou Xu , Kaiqing Ma , Fangjun Huo , Xuemei Qin , Kuanshou Zhang , Caixia Yin . HSA shrinkage optimizes the photostability of embedded dyes fundamentally to amplify their efficiency as photothermal materials. Chinese Chemical Letters, 2024, 35(8): 109223-. doi: 10.1016/j.cclet.2023.109223
5. [5]
  Yiqiao Chen , Ao Liu , Biwen Yang , Zhenzhen Li , Binggang Ye , Zhouyi Guo , Zhiming Liu , Haolin Chen . Photoluminescence and photothermal conversion in boric acid derived carbon dots for targeted microbial theranostics. Chinese Chemical Letters, 2024, 35(9): 109295-. doi: 10.1016/j.cclet.2023.109295
6. [6]
  Songtao Cai , Liuying Wu , Yuan Li , Soham Samanta , Jinying Wang , Bing Liu , Feihu Wu , Kaitao Lai , Yingchao Liu , Junle Qu , Zhigang Yang . Intermolecular hydrogen-bonding as a robust tool toward significantly improving the photothermal conversion efficiency of a NIR-II squaraine dye. Chinese Chemical Letters, 2024, 35(4): 108599-. doi: 10.1016/j.cclet.2023.108599
7. [7]
  Tianze Wang , Junyi Ren , Dongxiang Zhang , Huan Wang , Jianjun Du , Xin-Dong Jiang , Guiling Wang . Development of functional dye with redshifted absorption based on Knoevenagel condensation at 1-site in phenyl[b]-fused BODIPY. Chinese Chemical Letters, 2024, 35(6): 108862-. doi: 10.1016/j.cclet.2023.108862
8. [8]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
9. [9]
  Shaonan Tian , Yu Zhang , Qing Zeng , Junyu Zhong , Hui Liu , Lin Xu , Jun Yang . Core-shell gold-copper nanoparticles: Evolution of copper shells on gold cores at different gold/copper precursor ratios. Chinese Journal of Structural Chemistry, 2023, 42(11): 100160-100160. doi: 10.1016/j.cjsc.2023.100160
10. [10]
  Zhi Li , Wenpei Li , Shaoping Jiang , Chuan Hu , Yuanyu Huang , Maxim Shevtsov , Huile Gao , Shaobo Ruan . Legumain-triggered aggregable gold nanoparticles for enhanced intratumoral retention. Chinese Chemical Letters, 2024, 35(7): 109150-. doi: 10.1016/j.cclet.2023.109150
11. [11]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
12. [12]
  Ji Liu , Dongsheng He , Tianjiao Hao , Yumin Hu , Yan Zhao , Zhen Li , Chang Liu , Daquan Chen , Qiyue Wang , Xiaofei Xin , Yan Shen . Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters, 2024, 35(9): 109296-. doi: 10.1016/j.cclet.2023.109296
13. [13]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
14. [14]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
15. [15]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
16. [16]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
17. [17]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
18. [18]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
19. [19]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
20. [20]
  Ling-Ling Wu , Xiangchuan Meng , Qingyang Zhang , Xiaowan Han , Feiya Yang , Qinghua Wang , Hai-Yu Hu , Nianzeng Xing . Heavy-atom engineered hypoxia-responsive probes for precisive photoacoustic imaging and cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108663-. doi: 10.1016/j.cclet.2023.108663

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(177)
HTML views(5)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142